Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04571541 · ClinicalTrials.gov registry record

Endoscopic Management of Esophageal Wall Defects

A clinical trial of Esophageal Fistula and Esophageal Perforation, sponsored by Indiana University.

Completed
Registry status
150
Enrollment target
1
Study location

NCT04571541: Completed study of Esophageal Fistula and Esophageal Perforation, sponsored by Indiana University.

NCT04571541 is a study of Esophageal Fistula and Esophageal Perforation that has completed, run by Indiana University. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04571541, a study of Esophageal Fistula and Esophageal Perforation, has completed, sponsored by Indiana University.

COMPLETED
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

The study aim at comparing outcomes from the implementation of various endoscopic closure techniques including stenting and suturing on the healing and resolution of esophageal wall defects.

Primary Outcome

Resolution of esophageal wall defect

Interventions

  • DEVICE Stenting

Study Locations (1)

Indiana

  • Indiana University Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2014-07-01
Est. Completion 2025-07-01
Indiana University

890 total trials

What the finished NCT04571541 record still lists

NCT04571541 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.

The record links to 2 conditions, with Esophageal Fistula appearing as the primary indexed condition, and to 1 intervention - of which Stenting is the first listed.

NCT04571541 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT04571541 about?

NCT04571541 is a clinical study titled "Endoscopic Management of Esophageal Wall Defects". The study aim at comparing outcomes from the implementation of various endoscopic closure techniques including stenting and suturing on the healing and resolution of esophageal wall defects.

What is the current status of trial NCT04571541?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2014-07-01. Estimated completion is 2025-07-01.

What conditions does trial NCT04571541 study?

This clinical trial studies the following conditions: Esophageal Fistula, Esophageal Perforation.

What interventions are being tested in trial NCT04571541?

The interventions under investigation include: Stenting (DEVICE).

Who is sponsoring clinical trial NCT04571541?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04571541 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Esophageal Fistula

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04571541, the US trial registry maintained by the National Library of Medicine. NCT04571541 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.